Ketamine Infusion Therapy for Fibromyalgia

Chronic Pain · Ketamine Therapy · Reviewed by Samuel Caruthers, MD

If you have fibromyalgia, you have probably been told some version of the same thing more than once: your bloodwork is normal, your imaging is normal, and there is nothing structurally wrong. That is often true, and it is also why the condition is so frustrating to treat. The problem is usually not in the tissue where you feel the pain. It is in how your nervous system is processing the signal.

That distinction matters, because it explains why medications aimed at inflammation or tissue damage so often fall short, and it is the reason some patients with fibromyalgia are now being evaluated for ketamine infusion therapy.

This article explains what fibromyalgia appears to be at a mechanical level, why first-line treatments help some people and plateau for others, how ketamine works differently, and, just as importantly, what the evidence does and does not currently support. Ketamine is not a cure for fibromyalgia and it is not right for everyone. But for a specific group of patients, it is a reasonable option worth understanding.

Fibromyalgia is a problem of pain processing, not tissue damage

For decades fibromyalgia was poorly understood and, too often, poorly believed. That has changed. The current understanding is that fibromyalgia belongs to a category of pain sometimes called nociplastic pain, meaning pain that arises from altered processing within the nervous system rather than from ongoing injury or inflammation.

The mechanism most often described is central sensitization. In simple terms, the central nervous system becomes amplified. Signals that would normally register as mild pressure or minor discomfort get turned up and arrive as pain. The volume knob is stuck high, and it stays that way even when nothing new is happening in the body.

This is why fibromyalgia produces the pattern patients recognize immediately: widespread aching that moves and varies, tenderness to touch in places that should not hurt, deep fatigue that sleep does not resolve, and the cognitive fog that many people find as disabling as the pain itself.

The pain is real. The amplification is real. What is often missing is a treatment aimed at the amplification rather than at the places where the pain is felt.

Why first-line treatment helps some people and stalls for others

Three medications carry FDA approval for fibromyalgia: pregabalin, duloxetine, and milnacipran. Alongside them, most treatment plans include graded exercise, sleep management, and cognitive behavioral approaches, all of which have genuine evidence behind them and none of which should be dismissed.

For a meaningful number of patients, that combination works well enough to build a life around. This article is not written for those patients.

It is written for the ones who have worked through the approved medications, tolerated the side effects, done the physical therapy, corrected the sleep, and still find themselves at a level of daily pain they cannot function around. In fibromyalgia, partial response is common and complete response is not the norm. When several well-chosen treatments have each produced a modest improvement and the total is still not enough, it is reasonable to ask whether something with a different mechanism might add anything.

Where ketamine fits, and how it differs

Ketamine is an anesthetic medication that has been in clinical use since the 1960s. At the much lower doses used in pain infusions, it acts primarily as an NMDA receptor antagonist.

NMDA receptors are heavily involved in the process that produces and maintains central sensitization. When pain signaling repeats over time, these receptors contribute to a phenomenon sometimes described as wind-up, in which the nervous system becomes progressively more responsive to the same input. Blocking NMDA activity is, in theory, a way to interrupt that amplification directly rather than working around it.

That is a different target from anything else in the fibromyalgia toolkit. Anti-inflammatories address inflammation that is largely not the driver here. Opioids act on a pathway that responds poorly in centralized pain and carries real long-term risk. The approved fibromyalgia medications modulate signaling in useful but indirect ways. Ketamine aims at the amplification mechanism itself.

What the evidence actually shows

We would rather be straight with you here than oversell, because you have probably encountered enough overselling already.

Ketamine is not FDA approved for fibromyalgia. Its use in chronic pain is off-label, which is legal and common in medicine but worth saying plainly. The research base in fibromyalgia specifically consists largely of small studies, with variation in dosing, infusion duration, and how outcomes were measured. Several have reported meaningful short-term reductions in pain scores and in measures of central sensitization. Others have found benefit that faded over weeks. Large, long-term, high-quality trials in fibromyalgia have not been done.

What that adds up to is an honest and slightly unsatisfying answer: there is a plausible mechanism and encouraging but limited evidence. Some patients respond well. Some respond partially. Some do not respond at all, and there is currently no reliable test that predicts in advance which group you fall into.

Sleep, fatigue, and why they belong in the pain conversation

Almost every patient with fibromyalgia describes sleep that does not restore. You go to bed tired, you wake up tired, and the hours in between did not seem to count for anything. It is tempting to treat that as a consequence of the pain and therefore a secondary problem. It is not secondary.

Disrupted sleep lowers pain thresholds. Studies of sleep deprivation in healthy people show measurable increases in pain sensitivity after even a few poor nights. So the relationship runs in both directions: pain fragments sleep, and fragmented sleep amplifies pain. Once that loop is established it sustains itself without needing any new injury to keep it going.

This has a practical implication for how you judge any treatment, including this one. A reduction in pain that is modest on a numeric scale can produce a disproportionate improvement in function if it is enough to let you sleep. Conversely, if sleep is not addressed at all, the ceiling on what any pain treatment can achieve is lower than it should be.

The most useful question after treatment is often not how much the pain score moved, but whether you slept through the night.

What realistic improvement looks like

Patients sometimes arrive expecting one of two outcomes: the pain goes away, or nothing happens. In practice the meaningful result usually sits between those. A partial reduction that lets you sleep, return to some activity, and stop organizing every day around symptom management is a genuine result even though it is not a cure.

It is worth deciding in advance what would make treatment worth it for you, in terms of the things you actually want to do again. That gives you and your physician a real basis for judging whether to continue rather than relying on a number alone.

Who might be a reasonable candidate

Ketamine infusion therapy for fibromyalgia is generally considered for patients who have a confirmed diagnosis, who have tried appropriate first-line treatments without adequate relief, and who have no medical reason the medication would be unsafe.

Conditions that typically require caution or make ketamine inappropriate include poorly controlled high blood pressure, certain cardiac conditions, increased intracranial pressure, some psychiatric conditions including active psychosis, pregnancy, and a history of substance use disorder involving ketamine. This is not an exhaustive list, which is why the evaluation exists.

Realistically, the strongest candidates also tend to share something practical: they can commit to a series. Fibromyalgia is not usually addressed with a single infusion, and a patient who cannot reliably attend is set up for a disappointing outcome regardless of how well the medication might have worked.

What treatment involves

Infusions are given in the office with monitoring throughout. A pain protocol infusion runs considerably longer than the brief infusions used for mood conditions, and you will stay for a recovery period afterward.

You cannot drive yourself home. Ketamine affects perception and coordination for a period after the infusion ends, so every appointment requires someone to take you home. Patients who plan for this in advance, rather than discovering it partway through a series, are far more likely to complete treatment.

Most pain protocols begin with a series of infusions over a relatively compressed period, followed by less frequent maintenance if the initial series helps. The specific number and spacing depends on your response and is decided case by case rather than set in advance.

A note on cost and access

North Jersey Interventional Pain Center is an out-of-network practice, and ketamine infusion therapy for chronic pain is generally not covered by insurance. That is a real consideration and we would rather you weigh it before your first visit than after your third. During the consultation you will get specific numbers for what a series would involve, so the decision is made with full information rather than partway through.

Our Parsippany office serves patients from across Morris County, including Denville and Morris Plains, and we also see patients at our Clifton, Hackettstown, and Hamburg locations.

Frequently asked questions

Is ketamine approved for fibromyalgia?

No. Ketamine is FDA approved as an anesthetic. Its use for fibromyalgia and other chronic pain conditions is off-label. Off-label prescribing is legal and widespread in medicine, but it means the treatment has not been through the FDA approval process for this specific use.

How many infusions will I need?

There is no fixed number. Most pain protocols start with a series and then move to less frequent maintenance if the series helps. How many, and how far apart, depends on how you respond and is determined case by case.

Will it work for me?

We cannot tell you that in advance, and anyone who does is guessing. Response in fibromyalgia varies considerably. Some patients report substantial improvement, some partial, and some none. Your evaluation will cover what makes a response more or less likely in your particular situation.

Can I keep taking my current medications?

Usually yes, but that is a decision for your prescribing physician and it needs to be reviewed as part of your evaluation, because some medications interact with ketamine. Do not stop or change anything on your own.

Do I need a referral?

No. You can schedule a consultation directly. If you have recent records or imaging, bringing them helps, but a referral is not required.

Why can’t I drive afterward?

Ketamine affects perception, judgment, and coordination for a period after the infusion. Every patient needs someone to drive them home from every appointment. Plan for this before you begin a series.

Medical disclaimer. This article is for general educational purposes and is not medical advice, nor does it create a physician-patient relationship. Ketamine infusion therapy for fibromyalgia is an off-label use and is not FDA approved for this indication. Individual results vary, and no outcome is guaranteed. Do not start, stop, or change any medication based on this article. Discuss your specific circumstances with a qualified physician who has reviewed your full medical history. If you are experiencing a medical emergency, call 911.